← back to search

Maarten O. Blanken

Isala · NL
Area of research
Epidemiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Respiratory viral infections research, Neonatal Respiratory Health Research, Congenital Diaphragmatic Hernia Studies, and COVID-19 Impact on Reproduction.
h-index
13
citations
1,449
works
23
NIH funding
primary concept
email

Recent publications

Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants
Pediatric Pulmonology 2018cited by 52position: firstdoi
Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy
The Journal of Infectious Diseases 2017cited by 108position: middledoi
Cost-effectiveness of rule-based immunoprophylaxis against respiratory syncytial virus infections in preterm infants
European Journal of Pediatrics 2017cited by 39position: middledoi
Burden of Severe Respiratory Syncytial Virus Disease Among 33–35 Weeks’ Gestational Age Infants Born During Multiple Respiratory Syncytial Virus Seasons
The Pediatric Infectious Disease Journal 2016cited by 44position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

John Fullarton · Reading Museum2 papers (2016–2018)Xavier Carbonell‐Estrany · Hospital Clínic de Barcelona2 papers (2016–2018)Barry Rodgers‐Gray · Atomic Weapons Establishment2 papers (2016–2018)Evan J. Anderson · Emory University2 papers (2016–2018)Marcello Lanari · Azienda USL di Bologna2 papers (2016–2018)Margaret Sheridan‐Pereira · Coombe Women & Infants University Hospital2 papers (2016–2018)Gerard Notario · AbbVie (United States)2 papers (2016–2018)Bosco Paes · McMaster Children's Hospital2 papers (2016–2018)Louis Bont · Rome Foundation2 papers (2017–2017) · 1 papers (2018–2018)Elisabeth A. M. Sanders · Utrecht University1 papers (2017–2017)E. Rouffiac · Emory University1 papers (2016–2016)Maroeska M. Rovers · Radboud University Nijmegen1 papers (2017–2017)E. Grubb · AbbVie (United States)1 papers (2018–2018) · 1 papers (2017–2017) · 1 papers (2017–2017) · 1 papers (2017–2017)James D. Chappell · Vanderbilt University Medical Center1 papers (2017–2017)Martin L. Moore · Meissa Vaccines (United States)1 papers (2017–2017)Geert Frederix · Utrecht University1 papers (2017–2017)